Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Bupropion shows benefit for cancer-related fatigue in cancer survivors

ASCO 2026

29 May - 2 Jun 2026

Published: 1 Jun 2026

Views: 61

Rating:

Save

Dr Luke Joseph Peppone - University of Rochester Medical Center, Rochester, USA

At ASCO 2026 Dr Luke Peppone talks to ecancer about findings from a phase III trial evaluating bupropion for the treatment of moderate to severe cancer-related fatigue in patients who had completed surgery, radiotherapy, and/or intravenous anticancer therapy.

The study demonstrated significant improvements in fatigue symptoms with bupropion compared with placebo, supporting its potential use as a treatment option for cancer-related fatigue in clinical practice.

Related Videos

Real-world cardiovascular risks with novel hormonal therapies in advanced...

Dr Dalia Kaakour - University of California, Irvine, USA

Real-world cardiovascular risks with novel hormonal therapies in advanced prostate cancer ( Dr Dalia Kaakour - University of California, Irvine, USA )

Lutetium-177 PSMA-617 improves progression-free survival without worsening QoL...

Dr Michael Morris - Memorial Sloan Kettering Cancer Center, New York, USA

Lutetium-177 PSMA-617 improves progression-free survival without worsening QoL in mHSPC ( Dr Michael Morris - Memorial Sloan Kettering Cancer Center, New York, USA )

Key insights on breast cancer in Cape Verde

Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde

Key insights on breast cancer in Cape Verde ( Dr Pamela Borges - Agostinho Neto University Hospital, Praia, Cape Verde )

Best practice in precision medicine for prostate cancer

Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich

Best practice in precision medicine for prostate cancer ( Dr Elena Castro, Dr Pasquale Rescigno, Prof Gert Attard and Dr Axel Heidenreich )

Improving efficacy and toxicity reporting - and treatment insights from an...

Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado

Improving efficacy and toxicity reporting - and treatment insights from an oncologist patient ( Dr Ross Camidge - University of Colorado School of Medicine, Aurora, Colorado )

Treatment management of favourable risk and very favourable risk patients

Dr Guillermo de Velasco and Dr Marco Maruzzo

Treatment management of favourable risk and very favourable risk patients ( Dr Guillermo de Velasco and Dr Marco Maruzzo )

Breast cancer survivorship

Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg

Breast cancer survivorship ( Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg )

Burden and trends of breast cancer worldwide: Opportunities for prevention?

Dr Eileen Morgan, Dr Isabelle Soerjomataram and Dr Shalaka Joshi

Burden and trends of breast cancer worldwide: Opportunities for prevention? ( Dr Eileen Morgan, Dr Isabelle Soerjomataram and Dr Shalaka Joshi )

Patterns and correlates of multiple tobacco product use among people with HIV...

Dr Gina Kruse - University of Colorado School of Medicine, Aurora, Colorado

Patterns and correlates of multiple tobacco product use among people with HIV in India ( Dr Gina Kruse - University of Colorado School of Medicine, Aurora, Colorado )

More from ecancer